GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) CAS NO.161748-29-4

GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) CAS NO.161748-29-4

GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) CAS NO.161748-29-4

GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) CAS NO.161748-29-4

GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) CAS NO.161748-29-4

GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) is a multi-species collection of synthetic peptide fragments representing the major N-terminally truncated metabolite of glucagon-like peptide-1. This 28-amino acid peptide (C-terminal amide form) is available across multiple mammalian species, providing researchers with species-matched tools for comparative metabolic studies. The peptide exhibits weak GLP-1 receptor activity and serves as a valuable tool for investigating GLP-1 metabolism, clearance mechanisms, and receptor modulation. Supplied as high-purity lyophilized powder with HPLC-verified quality and species-specific sequence confirmation, this product enables cross-species research in diabetes, metabolism, and incretin biology.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat)
CAS NO.
161748-29-4
Appearance
White to off-white lyophilized powder
Molecular Formula
C140H214N36O43
Molecular Weight
 3089.48g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, acetic acid (0.1%), PBS (pH 7-8)

Endotoxin< 1.0 EU/mg
Biological Activity
Low-affinity ligands/weak antagonists of the GLP-1 receptor; potentially involved in the regulation of glucose homeostasis, and important metabolites for studying GLP-1 metabolism and clearance.
Storage Conditions
Store at -20°C or below, protected from light and moisture. After reconstitution, aliquot and store at -20°C
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

GLP-1 (9-36) amide acts as a low-affinity ligand for the GLP-1 receptor, functioning primarily as a weak antagonist or partial agonist. This peptide is generated in vivo through N-terminal cleavage of active GLP-1 (7-36) by dipeptidyl peptidase-4 (DPP-4), representing the major circulating metabolite. While it binds to GLP-1 receptors with significantly reduced affinity compared to the full-length peptide, it may modulate receptor signaling and contribute to the overall incretin effect. The C-terminal amidation enhances peptide stability and may influence receptor interaction. This product allows researchers to study species-specific differences in GLP-1 metabolism, receptor binding kinetics, and the physiological role of GLP-1 metabolites in glucose homeostasis.


2.PRODUCT INDICATIONS

Comparative Species Studies: Investigation of species-specific differences in GLP-1 metabolism and receptor pharmacology

Metabolic Research: Study of GLP-1 clearance mechanisms, DPP-4 activity, and incretin degradation pathways

Receptor Pharmacology: Evaluation of GLP-1 receptor binding affinity, signal transduction, and antagonist properties
Diabetes Research: Exploration of GLP-1 metabolite effects on glucose homeostasis and insulin secretion
Preclinical Development: Use in species-matched animal models for metabolic and pharmacokinetic studies
Cross-Species Validation: Comparison of peptide activity across human and common laboratory animal species


3.CLINICAL EFFICACY OF PRODUCT

Species Coverage: Available for human, bovine, guinea pig, mouse, porcine, and rat, enabling comprehensive cross-species research

High Purity: ≥95% by RP-HPLC with mass spectrometry confirmation of species-specific sequences

Sequence Accuracy: Each species variant verified for correct amino acid sequence and C-terminal amidation

Research Utility: Validated for receptor binding studies, metabolic assays, and species comparison experiments

Quality Documentation: Certificate of Analysis provided for each batch with purity, mass spec, and species identification

Technical Support: Access to species-specific application guidance and experimental design consultation


    4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.